NCB-0846 inhibited the TCF/LEF transcriptional activity of Wnt3a-treated HEK293 (Fig. 2f) and HCT116 (carrying CTNNB1 mutation) and DLD-1 (carrying APC mutation) colorectal cancer (Fig. 2g) cells. This evidence concerns the gene WNT3A and colorectal cancer.